Bernie J Eigl

10PUBLICATIONS
70CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 27, 2026
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

David C Müller, Andrew J Murtha, Jack V W Bacon

|Jun 20, 2025
ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer.

Gillian Vandekerkhove, Andrew J Murtha, David C Müller

|Feb 28, 2024
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer.

Nicolette M Fonseca, Corinne Maurice-Dror, Cameron Herberts

|Oct 20, 2023
Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma.

Daniel P Petrylak, Bernhard J Eigl, Saby George

|Apr 07, 2022
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.

Michiel S van der Heijden, Thomas Powles, Daniel Petrylak

|Oct 22, 2021
CRAFT-A Proposed Framework for Decentralized Clinical Trials Participation in Canada.

Stephen Sundquist, Gerald Batist, Kathy Brodeur-Robb

Pageof 2

Frequent Collaborators

5 joint publications

Gillian Vandekerkhove

5 joint publications

Alexander W Wyatt

3 joint publications

Cameron Herberts

3 joint publications

Andrew J Murtha